Ligand Pharmaceuticals
LGND
#4392
Rank
S$2.49 B
Marketcap
$136.78
Share price
1.28%
Change (1 day)
58.88%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.08

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.04. In 2022 the company made an earnings per share (EPS) of -$2.58 a decrease over its 2021 EPS that were of $4.51.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.08-180.72%
2022-$2.58-157.23%
2021$4.51-2571.43%
2020-$0.18-100.46%
2019$39.87353.48%
2018$8.791025%
2017$0.78-700%
2016-$0.13-100.87%
2015$15.061859.32%
2014$0.775.36%
2013$0.738.0704505322479E+18%
2012$0.0000000000-100%
2011$0.64-194.23%
2010-$0.68548.38%
2009-$0.10-98.7%
2008-$8.05-136.52%
2007$22.04-787.8%
2006-$3.20-14.58%
2005-$3.75-21.31%
2004-$4.77-55.15%
2003-$10.6381.33%
2002-$5.862.74%
2001-$5.71-45.93%
2000-$10.55-14.56%
1999-$12.35-45.52%
1998-$22.66-3.97%
1997-$23.60132.31%
1996-$10.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$18.43 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.47-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.56 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.37 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.42 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.07 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.17 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.67 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.35 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA